Sheldon Litwin to Survival Rate
This is a "connection" page, showing publications Sheldon Litwin has written about Survival Rate.
Connection Strength
0.104
-
Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial). Am J Cardiol. 2019 12 15; 124(12):1912-1917.
Score: 0.033
-
Coronary Computed Tomographic Angiography-Derived Fractional Flow Reserve Based on Machine Learning for Risk Stratification of Non-Culprit Coronary Narrowings in Patients with Acute Coronary Syndrome. Am J Cardiol. 2017 Oct 15; 120(8):1260-1266.
Score: 0.029
-
Risk factors for immediate prosthetic postmastectomy reconstruction. Am Surg. 1991 Aug; 57(8):514-21; discussion 522.
Score: 0.019
-
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol. 1995 Aug; 13(8):1860-70.
Score: 0.006
-
Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. Semin Oncol. 1995 Aug; 22(4 Suppl 9):18-29.
Score: 0.006
-
Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study. Cancer. 1993 Oct 01; 72(7):2124-33.
Score: 0.006
-
Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1993 Jun 15; 26(3):469-78.
Score: 0.005